Pillar Biosciences and AstraZeneca Expand Liquid Biopsy Access Partnership to China
NATICK, Mass. – December 8, 2025 – (PR NEWSWIRE) – Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based kitted liquid biopsy tumor profiling to include China. This expanded collaboration aims to deliver rapid, cost-effective, and clinically actionable genomic insights through liquid biopsy testing. By increasing the local […]